News & Events
Combinostics new PET quantification application cNeuro cPET receives FDA 510(k) clearance
New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows.
Combinostics New PET Quantification application cNeuro cPET released in Europe
New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows
AAIC 2023
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
SNMMI 2023
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Revolutionising Precision Medicine: PROMINENT Project will Enhance Diagnosis and Treatment of Neurodegenerative Diseases, Improving Patients’ Lives Across Europe
Stockholm, 14 June 2023 – Today, partners of the PROMINENT project announced the
104th German X-ray Congress
Visit us at booth Süd 36 at the 104th German X-ray Congress (RÖKO2023) to learn more about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Advanced MRI
Attending Advanced MRI? Stop by booth 4 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
ASNR 2023
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
MRI quantification: What you need to know when reading dementia and MS cases
Join our webinar on April 27, 2023, to hear Dr. Kevin Berger share his insights on the value of using MRI quantification and lesion detection.
